Dwie analizy badania ACTIV-6: wersja niezależna vs. oficjalna z "Medscape"
Analiza badania ACTIV-6, rozpoczeta w poprzednim wpisie, jest porównana do relacji czasopisma medycznego głównego nurtu. Tak nas okłamują najważniejsi profesorowie, nie tylko w kwestii Covid.
Analiza niezależna
Wewnątrz link do wywiadu (od 28 minuty o Iwermektynie w zapobieganiu zakrzepom.)
It’s time for integrity to happen again
Obserwacje z laboratorium diagnostycznego ColeDiagnostics: Szokujący wzrost nowotworów w tym u młodych ludzi, niewidywanie nigdy wcześniej skrzepy.
https://www.theepochtimes.com/from-wildfire-cancers-to-foot-long-clots-dr-ryan-cole-explains-the-dangers-of-the-spike-protein_4813813.html
Raport od uczestnika badania ACTIV-6 w pełni potwierdzający wnioski z niezaleznych analiz danych
“The ACTIV-6 patient confirmed much of what we suspected about the trial:
The participant contacted the trial staff within 5 days after symptoms started. They were enrolled in the trial 7 days after initial symptoms. Official “day 1” in the trial was 10 days after symptom onset. The medicine arrived a full 11 days after symptoms started.
The patients were taken at their word that they had a positive test; a self-administered rapid antigen test was sufficient.
Most patients never saw the trial staff, and didn’t speak to them on the phone after the first few days.
Patients were asked which drug they preferred to randomize for, opening real questions with regard to the validity of the randomization process.
A $100 Amazon gift card was used as inducement to complete all the forms in the trial. (This was not advertised before signing up for the trial.)
The patient in this case participated in the ACTIV-6 600 arm—whose recruitment is completed but results have not yet been published—and is part of the same overall trial as the recently published ACTIV-6 400 study.
I won’t reveal the patient’s name, as they have requested confidentiality, but they’ve provided proof that they were, in fact, part of the trial. This photo is of the trial instructions and the medicine bottle they received:”
Pełna analiza w linkowanym artykule
Wersja Oficjalna:
A tak badanie widzi oficalny “Medscape” w artykule “Ostateczny gwóźdź do trumny”
“Pierwotny cel badania był jasny: porównanie czasu do powrotu do zdrowia. Czy Iwermektyna pozwala ludziom na szybszy powrót do zdrowia?
Nie pomogło. Czas do wyzdrowienia, zdefiniowany jako pozostanie bez objawów przez 3 dni wynosił 12 dni w grupie Iwermektyny, i 13 dni w grupie placebo — to w granicach błędu statystycznego”
Ivermectin for COVID-19: Final Nail in the Coffin https://www.medscape.com/viewarticle/982852?src=WNL_trdalrt_pos1_ous_221031&uac=319374BY&impID=4811921
Dlaczego tak sformułowany wniosek jest manipulacją - o tym analizy niezależne powyżej, także wywiad z Dr Korry tutaj:
https://www.theepochtimes.com/dr-pierre-kory-the-war-on-hydroxychloroquine-ivermectin-and-other-cheap-drugs-to-treat-covid-19_4245042.html
Uaktualnienie:
Many have suspected that the U.S. government's "security assistance" to Ukraine — which as of November 15, 2022, had surpassed $98 billion1,2 — is a money laundering scheme to somehow ensure its own security, perhaps relating to questionable activities involving American biolabs in Ukraine.
With the sudden implosion of the cryptocurrency exchange FTX,3,4 suspicions of money laundering in Ukraine are gaining new support.
As scrutiny into FTX increases, people are finding more and more links between the ill-fated crypto exchange, the Democratic Party, Ukraine, the World Economic Forum (WEF) and even the suppression of COVID-19 treatments through the funding of fake science.
FTX, along with the Bill & Melinda Gates Foundation actually funded the TOGETHER trial,5 which sought to identify "effective repurposed therapies to prevent the disease progression of COVID-19." Using fraudulent trial protocols, this trial concluded that ivermectin and hydroxychloroquine were useless.6 Of course, to discourage criticism, the trial was given a "Trial of the Year" award for excellence.
https://articles.mercola.com/sites/articles/archive/2022/11/28/ukraine-war-money-laundering.aspx?ui=d90e7ee23f736e3fe79caa865ff2ed15a05fefdf54e3ba3681d683ddd0a14880&sd=20210522&cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20221128Z1_NB&cid=DM1290268&bid=1656250351